News & Analysis on Pharmaceutical Technology & Manufacturing
By Dan Stanton
- Last updated on
Next to China, and vaccine manufacturer Sinovac – who recently received updated cGMP accreditation from the CFDA – has announced Nan Wang, currently Vice President, has been appointed as Chief Financial Officer.
Wang has been with the company since 2001 and “has served as a valuable member of Sinovac's senior management team and developed a wealth of experience in the vaccine sector, communications with investors, fundraising, and financial management,” according to CEO Weidong Yin.